DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
Completed · Phase 3 · Has a placebo group
Conditions studied: Hypertension
In brief
This is a randomized, double-blind, placebo- and active-controlled study of a new experimental drug called darusentan. Darusentan is not currently approved by the United States Food and Drug Administration (FDA), which means that a doctor cannot prescribe this drug. The purpose of this study is to determine if darusentan is effective in reducing systolic and diastolic hypertension despite treatment with full doses of three or more antihypertensive drugs, including a diuretic. Subjects will be randomized to darusentan (optimized dose), an active comparator, or placebo, administered orally. The treatment period for this trial is 14 weeks.
Key facts
- Study ID
- NCT00389779
- Run by
- Gilead Sciences
- People needed
- 849
- Starts
- 2006-09-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2014-03-18
Who can join
Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Greystone Medical Research, LLC — Birmingham, Alabama, United States
- The Heart Center, PC — Huntsville, Alabama, United States
- Mulberry Medical Associates, PC — Montgomery, Alabama, United States
- Arizona Center for Clinical Research — Glendale, Arizona, United States
- Cardiovascular Consultants, Ltd. — Glendale, Arizona, United States
- Lovelace Scientific Resources, Inc — Phoenix, Arizona, United States
- Cochise Clinical Research — Sierra Vista, Arizona, United States
- Southwest Heart — Tucson, Arizona, United States
- HealthFirst Physician of AR, PA dba Convenient Care Clinic — Hot Springs, Arkansas, United States
- NEA Clinic — Jonesboro, Arkansas, United States
- Arkansas Primary Care Clinic, PA — Little Rock, Arkansas, United States
- Medical Investigations Inc. — Little Rock, Arkansas, United States
- Highgrove Medical Center — Bakersfield, California, United States
- Central Cardiology Medical Clinic — Bakersfield, California, United States
- Impact Clinical Trials — Beverly Hills, California, United States
- VA Greater Los Angeles Healthcare System — Los Angeles, California, United States
- Rancho Cucamonga Clinical Trials — Rancho Cucamonga, California, United States
- Pacific Heart Institute — Santa Monica, California, United States
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center — Torrance, California, United States
- Aurora Denver Cardiology Associates — Aurora, Colorado, United States
- Aurora Denver Cardiology Associates — Aurora, Colorado, United States
- Clinical Research of South Florida — Coral Gables, Florida, United States
- Doctors Medical Center of Walton County — DeFuniak Springs, Florida, United States
- Broward General Medical Center — Fort Lauderdale, Florida, United States
- Alabama Internal Medicine, PC — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.